Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Opinion & Events

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Heidelberg Pharma advances dual ATAC pipeline, secures $20M payment and eyes 2027 funding runway

    Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    PHARMASEAL and Viedoc integrate platforms to streamline clinical trial oversight

    Partnership combines PHARMASEAL’s trial management technology with Viedoc’s electronic data [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Opinion & Events

    Ciloa lands €6.5 million (£5.7 million) government backing to develop novel obesity and diabetes bio-drug

    Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Cereno taps global CRO for next big step in pulmonary hypertension drug trial

    Selection of CRO marks key milestone in advancing CS1 as [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Eleva doses first volunteers with new therapy targeting rare kidney disease

    Dosing of CPV-104 in healthy volunteers marks key milestone in [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    First-in-class cell therapy for rare mitochondrial disorder gains FDA fast track

    FDA recognition accelerates development of first-in-class mitochondrial cell therapy for [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Digital & Data

    Shift Bioscience tackles AI model flaws to advance rejuvenation discovery

    New study proposes AI-driven framework to refine gene target discovery [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Why generic AI fails pharma and how purpose-built AI is revolutionizing drug development

    Artificial intelligence (AI) is transforming many industries, but in pharma, [...]

    May 5, 2026
Previous676869Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Pace Life Sciences passes FDA inspection at North Carolina facility
    Categories: Clinical & Regulatory, Manufacturing & Supply Chain
  • CAMP4 wins Australian clearance to begin Phase 1/2 trial of SYNGAP1 therapy
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Novogene expands single-cell sequencing capability in Cambridge
    Categories: Genomics and sequencing, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top